Contexium

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Successor-in-Interest (Type 6 Parent Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 17 Jul 2027. The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interes…

Opportunity overview

Project name
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full...

Frequently asked questions

What is Successor-in-Interest (Type 6 Parent Clinical Trial Optional)?

Successor-in-Interest (Type 6 Parent Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 17 Jul 2027. The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interes…

Who is funding Successor-in-Interest (Type 6 Parent Clinical Trial Optional)?

Successor-in-Interest (Type 6 Parent Clinical Trial Optional) is funded by National Institutes of Health.

When is the deadline to apply for Successor-in-Interest (Type 6 Parent Clinical Trial Optional)?

The application deadline is 17 Jul 2027 00:00 (UTC).

Where will the Successor-in-Interest (Type 6 Parent Clinical Trial Optional) project take place?

The project location(s) are: United States.

How can I apply for Successor-in-Interest (Type 6 Parent Clinical Trial Optional)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.